Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion

Overview of attention for article published in Journal of Molecular Medicine, February 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 38 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

Engineered antibodies and uses thereof

Grant US-11702480-B2

United States of America

ENGINEERED ANTIBODIES AND USES THEREOF

Application WO-2018094282-A1

World Intellectual Property Organisation (WIPO)

Biological materials and uses thereof

Grant US-9803013-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.